BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3555282)

  • 1. Class II antigen expression and inflammatory cells in the Guillain-Barré syndrome.
    Pollard JD; Baverstock J; McLeod JG
    Ann Neurol; 1987 Apr; 21(4):337-41. PubMed ID: 3555282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schwann cells in acute and chronic Guillain-Barré syndrome].
    Cadoni A; Zicca A; Schenone A; De Martini I; Mancardi GL
    Boll Soc Ital Biol Sper; 1987 May; 63(5):399-405. PubMed ID: 3651249
    [No Abstract]   [Full Text] [Related]  

  • 3. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy.
    Pollard JD; McCombe PA; Baverstock J; Gatenby PA; McLeod JG
    J Neuroimmunol; 1986 Dec; 13(2):123-34. PubMed ID: 3023444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration.
    Pilartz M; Jess T; Indefrei D; Schröder JM
    Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.
    Hauser SL; Bhan AK; Gilles F; Kemp M; Kerr C; Weiner HL
    Ann Neurol; 1986 Jun; 19(6):578-87. PubMed ID: 3524414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
    J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic Guillain-Barre syndrome].
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):231-4, 253-4. PubMed ID: 1954797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome.
    Wanschitz J; Maier H; Lassmann H; Budka H; Berger T
    Brain; 2003 Sep; 126(Pt 9):2034-42. PubMed ID: 12847075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
    Chaux P; Moutet M; Faivre J; Martin F; Martin M
    Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex class II antigen expression in nerves in leprosy; an immunoelectronmicroscopical study.
    Cowley SA; Gschmeissner SE; Negesse Y; Curtis J; Turk JL
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):560-5. PubMed ID: 2401839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients.
    Brechenmacher C; Vital C; Deminiere C; Laurentjoye L; Castaing Y; Gbikpi-Benissan G; Cardinaud JP; Favarel-Garrigues JP
    Clin Neuropathol; 1987; 6(1):19-24. PubMed ID: 3552352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological characterization of sural nerve biopsies from patients with Guillain-Barré syndrome.
    Nyland H; Matre R; Mørk S
    Ann Neurol; 1981; 9 Suppl():80-6. PubMed ID: 7224617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory neuropathies.
    Hughes RA
    Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
    Sharief MK; McLean B; Thompson EJ
    Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute polyradiculoneuropathy of Guillain-Barré. Critical review of potential etiopathogeneses].
    Guadagnino M; Petitto F
    Riv Neurol; 1985; 55(6):402-23. PubMed ID: 3008302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells.
    Duan RS; Jin T; Yang X; Mix E; Adem A; Zhu J
    Glia; 2007 May; 55(7):772-6. PubMed ID: 17357152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widenings of the myelin lamellae in a typical Guillain-Barré syndrome.
    Vallat JM; Leboutet MJ; Jauberteau MO; Tabaraud F; Couratier P; Akani F
    Muscle Nerve; 1994 Apr; 17(4):378-80. PubMed ID: 8170482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.